Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02683694|
Recruitment Status : Completed
First Posted : February 17, 2016
Last Update Posted : March 9, 2018
During the last decade optical coherence tomography (OCT) extended the possibilities for in vivo macula diagnostic and was increasingly used for pre- and post-operative imaging of retinal diseases. Spectral-domain optical coherence tomography (SD-OCT) with its increased scanning speed and image-resolution provides more detailed information of microstructures in the macula.
Epiretinal membrane (ERM), lamellar macular hole, macular hole and vitreomacular traction syndrome are disorders involving the posterior pole of the eyeball with consecutive vision loss. In patients with loss of vision and metamorphopsia disturbing their lifestyle, vitrectomy and membrane peeling is usually performed to remove traction and the ERM.
Different study groups showed that intraoperative use of SD-OCT is possible and improves the quality of peeling surgery.
|Condition or disease||Intervention/treatment||Phase|
|Macular Diseases||Device: iOCT||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||81 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases|
|Study Start Date :||February 2015|
|Actual Primary Completion Date :||May 2017|
|Actual Study Completion Date :||August 2017|
iOCT is performed
the number of subjects that can be peeled without dye are assessed
Other Name: intraoperative OCT (iOCT)
- peeling without staining [ Time Frame: intraoperative (10-15 minutes) ]number of patients that could be peeled without use of a dye
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02683694
|Vienna, Austria, 1140|
|Principal Investigator:||Oliver Findl, Prof||Vienna Institute for Research in Ocular Surgery|